Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP programmes and uptake news

Show

From To
Generic HIV prevention drug coming in 2020, Gilead says

"Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early launch of a generic version of Truvada into the market in 2020, a year earlier than required," wrote Douglas Brooks, Gilead's executive director for community engagement, in an email shared with NBC News by the advocacy group PrEP4All.

Published
09 May 2019
From
CNBC
Official Statement responding to Gilead Sciences’ announcement that it will allow Teva to Manufacture a Generic Version of Truvada

While Gilead’s announcement that generic Truvada will be made available in the United States a year early is a victory for the LGBTQ+ community, for HIV activists, and for U.S. taxpayers, this should only be the beginning. Even their announcement today leaves Gilead with exclusive rights to Truvada as PrEP for another 15 months and Teva as the only generic manufacturer on the U.S. market. This will do little to reduce the price in a way that will increase access and PrEP4All remains suspicious of the terms and lack of transparency surrounding the Teva settlement.

Published
09 May 2019
From
Breakthepatent.org
How About Letting Nurses Provide PrEP to Patients?

Because it’s so important to make sure that pre-exposure prophylaxis (PrEP) is available to people at risk of acquiring HIV, a team of investigators at the University of Ottawa in Ontario, Canada, has proposed that nurses be on the front lines of providing PrEP. Most current guidelines for PrEP are not written for non-prescribing clinicians such as nurses, even though they may be uniquely positioned to assess patients and recommend PrEP.

Published
03 May 2019
From
Contagion Live
PrEP vs. Privacy

When you’re a young adult on your parents’ insurance, your health decisions are a family affair. And that’s a problem for HIV prevention.

Published
29 April 2019
From
Slate
Ireland: Taoiseach and Minister for Health confirm introduction of PrEP programme in 2019

Taoiseach Leo Varadkar welcomed the publication of a draft report by the Health Information and Quality Authority (HIQA) on the introduction of a pre-exposure prophylaxis (PrEP) programme aimed at preventing HIV. Health Minister Simon Harris encouraged interested parties and members of the public to give their feedback on the draft report during the consultation process which runs to 28th of May, The public consultation is at HIQA’s website: https://www.hiqa.ie/reports-and-publications/consultation/draft-hta-prep-programme

Published
23 April 2019
From
Irish Ministry of Health
Hivpoint Helsinki welcomes Pre-Exposure Prophylaxis – Finnish national guidelines are here, and generic medicines hit the market soon

The National Institute for Health and Welfare recommends PrEP for people with a high risk for HIV transmission. As a part of a comprehensive prevention program, PrEP has reduced new HIV transmissions in all countries where it is available. When used correctly, PrEP provides up to 99% reduction in HIV risk. The Finnish national guidelines are released today, 17 April 2019.

Published
17 April 2019
From
Hivpoint
Pre-Exposure Prophylaxis for HIV officially launched in Hanoi

Pre-Exposure Prophylaxis (PrEP) service for HIV prevention was officially launched in Hanoi on April 16.

Published
17 April 2019
From
Vietnam+
London councils agree to take 60% new PrEP trial patients, but it might not be enough

A stalemate over who would take more patients on to PrEP trial has ended. London councils have agreed to increase places on city PrEP trial.

Published
15 April 2019
From
Gay Star News
More Londoners to receive HIV prevention medicine

In a boost to HIV prevention in the capital, London boroughs have agreed to provide over 4,000 extra places on the PrEP Impact Trial. The trial – a national programme led by NHS England in partnership with Public Health England and local authorities – supplies PrEP (an HIV prevention medicine) free of charge to individuals considered to be at high risk of exposure to HIV. The expansion, which will take place over the coming weeks, represents a 60% increase in the trial places available to Londoners. London already accounts for 7,609 trial places – a higher figure than the rest of England combined.

Published
12 April 2019
From
London Councils
PrEP Impact Trial Update – April 2019

The PrEP Oversight Board met on 20 March and the main item on the agenda was to receive an update on trial site capacity and commissioner approvals of additional trial places.

Published
04 April 2019
From
NHS England

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.